U.S. Opens Trade Injury Investigations Into Choline Salts From China
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The U.S. International Trade Commission has opened preliminary investigations into choline salts imported from China. The case will examine whether these imports are being sold in the United States at unfairly low prices or supported by Chinese government subsidies, and whether that is harming U.S. industry. Importers, buyers, and businesses using choline salts should watch the case closely. If the investigations move forward, the imports could face antidumping or countervailing duties, which may raise costs or change sourcing decisions. The preliminary injury decision is due by August 10, 2026, with the Commission’s views sent to the Commerce Department by August 17, 2026.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- The ITC has started preliminary antidumping and countervailing duty investigations into choline salts from China.
- The investigations will assess whether Chinese imports are harming or threatening U.S. industry.
- A preliminary determination is expected by August 10, 2026, unless Commerce extends the timeline.
Obligations
What this law requires
The U.S. International Trade Commission must reach a preliminary determination in the antidumping and countervailing duty investigations concerning certain choline salts from China unless Commerce extends the initiation period.
The U.S. International Trade Commission must transmit its views on the preliminary investigations to the Department of Commerce within five business days after the preliminary determination.